针针的成本效益对于慢性腰部疼痛的老年人来说
Patricia M Herman1, Sam Mann1, Lynn L DeBar2
1RAND, Santa Monica, CA.
Spine
|January 6, 2026
概括
增强针 (EA) 对患有慢性腰部疼痛 (CLBP) 的老年人来说是节省成本的. 标准针 (SA) 可能具有成本效益,提供显著的质量调整寿命 (QALYs) 和与通常医疗护理 (UMC) 相比更好的结果.
科学领域:
- 卫生经济学 卫生经济学
- 老年医学 老年医学
- 疼痛管理 疼痛管理
背景情况:
- 慢性腰部疼痛 (CLBP) 是普遍的和昂贵的,特别是在老年人中.
- 目前的治疗方法往往涉及非指导方针一致的药物和程序.
- 针对CLBP有效,但专门针对老年人的研究是有限的.
研究的目的:
- 为了确定1年的成本效益增加标准针 (SA) 或增强针 (EA) 常规医疗 (UMC) 与单独的UMC对老年人CLBP.
- 从医疗保健部门和医疗保险的角度来比较结果.
主要方法:
- 一个预先计划的经济评估与一个随机临床试验,涉及三个美国医疗保健系统.
- 进行了成本效益和成本效益分析,将SA (≤15次) 和EA (SA + ≤6次) 与UMC进行比较.
- 偏差纠正和加速启动技术产生了95%的置信区间 (CI).
主要成果:
- 强化针 (EA) 将医疗保健部门的成本降低了491美元/参与者,Medicare成本降低了421美元/参与者,统计学上显著的收益为0.037个质量调整寿命年 (QALY).
- 此外,EA还导致残疾分数在临床上有意义的改善 (CMI) 显著增加 (18.5%分).
- 标准针 (SA) 比UMC更昂贵,增量成本效益率为52,897美元/QALY;QALY收益和CMI增加没有统计学意义.
结论:
- 从医疗保健部门和医疗保险的角度来看,强化针 (EA) 对患有CLBP的老年人来说是节省成本的.
- 标准针 (SA) 可能具有成本效益,在QALY和功能改善方面显示出潜在的益处.
- 这些发现支持将针,特别是EA,整合到UMC中,用于老年人群中管理CLBP.
相关概念视频
Drug Dosing: Geriatric Patients
400
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
400
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
868
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
868
Pharmacodynamics in Geriatric Patients: Effects of Age
376
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
376
Peripheral Artery Disease V: Postoperative Nursing Management
637
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
637


